Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

17.09
-1.2300-6.71%
Post-market: 18.000.9100+5.32%19:04 EST
Volume:1.16M
Turnover:19.98M
Market Cap:1.57B
PE:-6.08
High:18.57
Open:18.44
Low:16.81
Close:18.32
52wk High:19.16
52wk Low:5.15
Shares:91.71M
Float Shares:75.46M
Volume Ratio:1.43
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8108
EPS(LYR):-4.9960
ROE:-93.04%
ROA:-46.48%
PB:5.94
PE(LYR):-3.42

Loading ...

Immunome Initiated at Buy by Truist Securities

Dow Jones
·
Dec 01

Truist Initiates Immunome at Buy With $36 Price Target

MT Newswires Live
·
Dec 01

Immunome Inc : Truist Securities Initiates Coverage With Buy Rating; Price Target $36

THOMSON REUTERS
·
Dec 01

Immunome to Present at Upcoming Investor Conferences

Reuters
·
Nov 25

Lake Street Sticks to Their Buy Rating for Immunome (IMNM)

TIPRANKS
·
Nov 18

Immunome Is Maintained at Overweight by Stephens & Co.

Dow Jones
·
Nov 17

Immunome Inc : Stephens Raises Target Price to $33 From $25

THOMSON REUTERS
·
Nov 17

Stock Track | Immunome Inc. Surges 5.17% After TD Cowen Reaffirms Buy Rating

Stock Track
·
Nov 12

Stock Track | Immunome Inc. Soars 5.17% Following Analyst's Buy Rating Reaffirmation

Stock Track
·
Nov 12

Immunome’s Strategic Clinical Advancements and Financial Alignment Justify Buy Rating

TIPRANKS
·
Nov 12

Immunome, Inc. Reports Q3 2025 Financial Results

TIPRANKS
·
Nov 11

Craig-Hallum Reaffirms Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Nov 08

Immunome’s Strategic Advances and Promising Pipeline Justify Buy Rating

TIPRANKS
·
Nov 07

Immunome Q3 EPS $(0.65) Misses $(0.58) Estimate

Benzinga
·
Nov 07

Immunome Q3 net loss widens, expects current cash to fund operations into 2027

Reuters
·
Nov 07

Immunome Grants Stock Options to New Employees Under 2024 Inducement Plan

Reuters
·
Nov 05

A Closer Look at Immunome (IMNM) Valuation Following Latest Oncology Conference Spotlight

Simply Wall St.
·
Nov 05

Immunome (IMNM) Gets a Buy from Piper Sandler

TIPRANKS
·
Nov 04

Immunome Inc. to Present at Guggenheim Healthcare Innovation Conference

Reuters
·
Oct 31

argenx Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Oct 30